Procaps Group, S.A Income from Continuous Operations 2020-2023 | PROCF
Procaps Group, S.A income from continuous operations from 2020 to 2023. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Procaps Group, S.A Annual Income from Continuous Operations (Millions of US $) |
2022 |
$43 |
2021 |
$-101 |
2020 |
$-10 |
2020 |
$-13 |
2019 |
$-17 |
2019 |
$-0 |
2018 |
$-0 |
Procaps Group, S.A Quarterly Income from Continuous Operations (Millions of US $) |
2023-09-30 |
$8 |
2023-06-30 |
$27 |
2023-03-31 |
$7 |
2022-12-31 |
$10 |
2022-09-30 |
$23 |
2022-06-30 |
$-7 |
2022-03-31 |
$16 |
2021-12-31 |
$28 |
2021-09-30 |
$-111 |
2021-06-30 |
$-1 |
2021-03-31 |
$-17 |
2020-12-31 |
$-6 |
2020-09-30 |
$-1 |
2020-06-30 |
$-4 |
2020-03-31 |
$2 |
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
$-0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|